Cargando…
Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents
Intravitreal injection of anti-vascular endothelial growth factor is currently the preferred treatment for several posterior segment diseases, including age-related macular degeneration and diabetic retinopathy, as well as macular edema and retinal vein occlusion. As an invasive procedure it involve...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rambam Health Care Campus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6185999/ https://www.ncbi.nlm.nih.gov/pubmed/30180932 http://dx.doi.org/10.5041/RMMJ.10348 |
_version_ | 1783362787414638592 |
---|---|
author | Labardini, Cecilia P. Blumenthal, Eytan Z. |
author_facet | Labardini, Cecilia P. Blumenthal, Eytan Z. |
author_sort | Labardini, Cecilia P. |
collection | PubMed |
description | Intravitreal injection of anti-vascular endothelial growth factor is currently the preferred treatment for several posterior segment diseases, including age-related macular degeneration and diabetic retinopathy, as well as macular edema and retinal vein occlusion. As an invasive procedure it involves risks. The most significant risk is infectious endophthalmitis, a sight-threatening and even a globe-threatening acute fulminant condition. Most common pathogens include Streptococcus and Staphylococcus species, surprisingly originating from the patient’s, surgeon’s, or nurse’s mouth. Infectious endophthalmitis may have devastating and irreversible effect, with Streptococcus-induced cases having the worst visual outcome. It is therefore crucial for clinicians to promptly recognize and treat such conditions, and, far more important, to put in place protective and preventive measures against this rare, but sight-threatening complication. To that end, this paper describes the most common pathogens causing endophthalmitis after IVI of anti-VEGF, and defines their source, to aid the physician in developing strategies to prevent this catastrophic infection. |
format | Online Article Text |
id | pubmed-6185999 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Rambam Health Care Campus |
record_format | MEDLINE/PubMed |
spelling | pubmed-61859992018-10-22 Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents Labardini, Cecilia P. Blumenthal, Eytan Z. Rambam Maimonides Med J Special Issue Celebrating the 80th Anniversary of Rambam Health Care Campus Intravitreal injection of anti-vascular endothelial growth factor is currently the preferred treatment for several posterior segment diseases, including age-related macular degeneration and diabetic retinopathy, as well as macular edema and retinal vein occlusion. As an invasive procedure it involves risks. The most significant risk is infectious endophthalmitis, a sight-threatening and even a globe-threatening acute fulminant condition. Most common pathogens include Streptococcus and Staphylococcus species, surprisingly originating from the patient’s, surgeon’s, or nurse’s mouth. Infectious endophthalmitis may have devastating and irreversible effect, with Streptococcus-induced cases having the worst visual outcome. It is therefore crucial for clinicians to promptly recognize and treat such conditions, and, far more important, to put in place protective and preventive measures against this rare, but sight-threatening complication. To that end, this paper describes the most common pathogens causing endophthalmitis after IVI of anti-VEGF, and defines their source, to aid the physician in developing strategies to prevent this catastrophic infection. Rambam Health Care Campus 2018-10-04 /pmc/articles/PMC6185999/ /pubmed/30180932 http://dx.doi.org/10.5041/RMMJ.10348 Text en Copyright: © 2018 Labardini and Blumenthal. This is an open-access article. All its content, except where otherwise noted, is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Special Issue Celebrating the 80th Anniversary of Rambam Health Care Campus Labardini, Cecilia P. Blumenthal, Eytan Z. Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents |
title | Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents |
title_full | Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents |
title_fullStr | Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents |
title_full_unstemmed | Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents |
title_short | Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents |
title_sort | causative pathogens in endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents |
topic | Special Issue Celebrating the 80th Anniversary of Rambam Health Care Campus |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6185999/ https://www.ncbi.nlm.nih.gov/pubmed/30180932 http://dx.doi.org/10.5041/RMMJ.10348 |
work_keys_str_mv | AT labardiniceciliap causativepathogensinendophthalmitisafterintravitrealinjectionofantivascularendothelialgrowthfactoragents AT blumenthaleytanz causativepathogensinendophthalmitisafterintravitrealinjectionofantivascularendothelialgrowthfactoragents |